期刊文献+

奥美拉唑注射液终止心房颤动1例报道

Atrial fibrillation terminated by Omeprazole injection: A case reports
原文传递
导出
摘要 心房颤动(房颤)是一种十分常见的心律失常,其主要危害是可引发脑卒中、恶性心律失常及左心房功能失调[1]。尤其是持续性快速房颤,可危及患者生命或明显降低患者生活质量,因此即时终止房颤是当今心血管科的重要命题之一。本院3年前在使用奥美拉唑注射液治疗十二指肠球部溃疡时.
作者 赵明文 孙燕 赵志元 鄢欢 ZHAO Ming-wen;SUN Yan;ZHAO Zhi-yuan;YAN Huan(Liuliping Town Central Hospital,Danjiangkou City,Shiyan 442700,China)
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2018年第A02期75-76,共2页 Chinese Journal of Practical Internal Medicine
关键词 奥美拉唑 终止 心房颤动 Omeprazole termination atrial fibrillation
  • 相关文献

参考文献4

二级参考文献17

  • 1周自强,胡大一,陈捷,张仁汉,李奎宝,赵秀丽.中国心房颤动现状的流行病学研究[J].中华内科杂志,2004,43(7):491-494. 被引量:1402
  • 2黄从新,马长生,杨延宗,黄德嘉,张澍,江洪,杨新春,吴书林,马坚,刘少稳,李莉,曹克将,王方正,陈新.心房颤动:目前的认识和治疗建议(二)[J].中华心律失常学杂志,2006,10(3):167-197. 被引量:269
  • 3Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines ( Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) :developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation, 2006,114 : e257-354. 被引量:1
  • 4Fang MC,Chang Y,Hylek EM,et al. Advanced age, anticoagulation intensity,and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation. Ann Intern Med,2004,141:745-752. 被引量:1
  • 5Fang MC, Go AS, Hylek EM, et al. Age and the risk of warfarin-associated hemorrhage:the anticoagulation and risk factors in atrial fibrillation study. J Am Geriatr Soc,2006,54 : 1231-1236. 被引量:1
  • 6Hylek EM, Evans-Molina C, Shea C, et al. Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation. Circulation ,2007,115:2689-2696. 被引量:1
  • 7Mant J, Hobbs FD, Fletcher K, et al. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA ) : a randomised controlled trial. Lancet ,2007,370:493-503. 被引量:1
  • 8Oral H,Chugh A,Ozaydin M,et al. Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation. Circulation ,2006,114:759-765. 被引量:1
  • 9Calkins H, Brugada J, Packer DL, et al. HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation : recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. Heart Rhythm,2007,4:816-861. 被引量:1
  • 10Pappone C, Rosanio S, Augello G, et al. Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study. J Am Coll Cardiol,2003,42 : 185-197. 被引量:1

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部